Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (261-270 of 953) with videos related to

Pageof 96
Sort By:
Neurology|August 14, 2020
Sex differences in CSF biomarkers vary by Alzheimer disease stage and <i>APOE</i> ε4 genotypeRosha Babapour Mofrad, Betty M Tijms, Philip Scheltens, et al.
The Journal of Clinical Psychiatry|November 4, 2017
The Diagnostic Challenge of the Late-Onset Frontal Lobe Syndrome: Clinical Predictors for Primary Psychiatric Disorders Versus Behavioral Variant Frontotemporal DementiaEverard G B Vijverberg, Flora Gossink, Welmoed Krudop, et al.
Molecular Psychiatry|August 22, 2019
Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer's diseaseSara Hijazi, Tim S Heistek, Philip Scheltens, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 11, 2016
Random forest to differentiate dementia with Lewy bodies from Alzheimer's diseaseMeenakshi Dauwan, Jessica J van der Zande, Edwin van Dellen, et al.
Journal of Alzheimer'S Disease : JAD|May 1, 2013
Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE ε4 carriersFlora H Duits, Maartje I Kester, Peter G Scheffer, et al.
Frontiers in Neurology|November 2, 2016
Magnetoencephalography for the Detection of Intervention Effects of a Specific Nutrient Combination in Patients with Mild Alzheimer's Disease: Results from an Exploratory Double-Blind, Randomized, Controlled StudyElisabeth C W van Straaten, Hanneke de Waal, Marieke M Lansbergen, et al.
European Radiology|January 14, 2017
Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic populationJules J Claus, Salka S Staekenborg, Dana C Holl, et al.
Journal of Neurology|October 1, 2008
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementiaElisabeth C W van Straaten, Danielle Harvey, Philip Scheltens, et al.
Journal of Sleep Research|November 23, 2006
Peripheral electrical nerve stimulation and rest-activity rhythm in Alzheimer's diseaseKoene R A Van Dijk, Marijn W Luijpen, Eus J W Van Someren, et al.
Dementia and Geriatric Cognitive Disorders|November 2, 2006
Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer diseaseWiesje M van der Flier, Salka Staekenborg, Yolande A L Pijnenburg, et al.
Pageof 96

Showing results (261-270 of 953) with videos related to

Sort By:
Pageof 96
Neurology|August 14, 2020
Sex differences in CSF biomarkers vary by Alzheimer disease stage and <i>APOE</i> ε4 genotypeRosha Babapour Mofrad, Betty M Tijms, Philip Scheltens, et al.
The Journal of Clinical Psychiatry|November 4, 2017
The Diagnostic Challenge of the Late-Onset Frontal Lobe Syndrome: Clinical Predictors for Primary Psychiatric Disorders Versus Behavioral Variant Frontotemporal DementiaEverard G B Vijverberg, Flora Gossink, Welmoed Krudop, et al.
Molecular Psychiatry|August 22, 2019
Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer's diseaseSara Hijazi, Tim S Heistek, Philip Scheltens, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 11, 2016
Random forest to differentiate dementia with Lewy bodies from Alzheimer's diseaseMeenakshi Dauwan, Jessica J van der Zande, Edwin van Dellen, et al.
Journal of Alzheimer'S Disease : JAD|May 1, 2013
Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE ε4 carriersFlora H Duits, Maartje I Kester, Peter G Scheffer, et al.
Frontiers in Neurology|November 2, 2016
Magnetoencephalography for the Detection of Intervention Effects of a Specific Nutrient Combination in Patients with Mild Alzheimer's Disease: Results from an Exploratory Double-Blind, Randomized, Controlled StudyElisabeth C W van Straaten, Hanneke de Waal, Marieke M Lansbergen, et al.
European Radiology|January 14, 2017
Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic populationJules J Claus, Salka S Staekenborg, Dana C Holl, et al.
Journal of Neurology|October 1, 2008
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementiaElisabeth C W van Straaten, Danielle Harvey, Philip Scheltens, et al.
Journal of Sleep Research|November 23, 2006
Peripheral electrical nerve stimulation and rest-activity rhythm in Alzheimer's diseaseKoene R A Van Dijk, Marijn W Luijpen, Eus J W Van Someren, et al.
Dementia and Geriatric Cognitive Disorders|November 2, 2006
Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer diseaseWiesje M van der Flier, Salka Staekenborg, Yolande A L Pijnenburg, et al.
Pageof 96